Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Gene Synthesis Market, by Method
1.4.2 North America Gene Synthesis Market, by Service Type
1.4.3 North America Gene Synthesis Market, by Application
1.4.4 North America Gene Synthesis Market, by End User
1.4.5 North America Gene Synthesis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Acquisition and Mergers
3.2.2 Partnerships, Collaborations and Agreements
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Dec – 2021, Nov) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2017, Jul – 2021, Aug) Leading Players
Chapter 4. North America Gene Synthesis Market by Method
4.1 North America Solid-phase Synthesis Market by Country
4.2 North America Chip-based Synthesis Market by Country
4.3 North America PCR-based Enzyme Synthesis Market by Country
Chapter 5. North America Gene Synthesis Market by Service Type
5.1 North America Antibody DNA Synthesis Market by Country
5.2 North America Viral DNA Synthesis Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Gene Synthesis Market by Application
6.1 North America Gene & Cell Therapy Development Market by Country
6.2 North America Vaccine Development Market by Country
6.3 North America Disease Diagnosis Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Gene Synthesis Market by End User
7.1 North America Academic & Government Research Institutes Market by Country
7.2 North America Biotechnology & Pharmaceutical Companies Market by Country
7.3 North America Contract Research Organizations Market by Country
Chapter 8. North America Gene Synthesis Market by Country
8.1 US Gene Synthesis Market
8.1.1 US Gene Synthesis Market by Method
8.1.2 US Gene Synthesis Market by Service Type
8.1.3 US Gene Synthesis Market by Application
8.1.4 US Gene Synthesis Market by End User
8.2 Canada Gene Synthesis Market
8.2.1 Canada Gene Synthesis Market by Method
8.2.2 Canada Gene Synthesis Market by Service Type
8.2.3 Canada Gene Synthesis Market by Application
8.2.4 Canada Gene Synthesis Market by End User
8.3 Mexico Gene Synthesis Market
8.3.1 Mexico Gene Synthesis Market by Method
8.3.2 Mexico Gene Synthesis Market by Service Type
8.3.3 Mexico Gene Synthesis Market by Application
8.3.4 Mexico Gene Synthesis Market by End User
8.4 Rest of North America Gene Synthesis Market
8.4.1 Rest of North America Gene Synthesis Market by Method
8.4.2 Rest of North America Gene Synthesis Market by Service Type
8.4.3 Rest of North America Gene Synthesis Market by Application
8.4.4 Rest of North America Gene Synthesis Market by End User
Chapter 9. Company Profiles
9.1 Genscript Biotech Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.5.4 Geographical Expansions:
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Acquisition and Mergers:
9.2.5.3 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 Brooks Automation, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Boster Biological Technology
9.4.1 Company Overview
9.5 Twist Bioscience Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional & Segmental Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.5.5.3 Product Launches and Product Expansions:
9.5.5.4 Geographical Expansions:
9.6 Danaher Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.6.5.2 Acquisition and Mergers:
9.6.5.3 Geographical Expansions:
9.7 Biomatik Corporation
9.7.1 Company Overview
9.8 ProteoGenix
9.8.1 Company Overview
9.9 ProMab Biotechnologies, Inc.
9.9.1 Company Overview
9.10. OriGene Technologies, Inc.
9.10.1 Company Overview
Unique Offerings 
